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Authors’ Response to: ‘‘Health Opportunity
Costs and Expert Elicitation: A Comment on
Soares et al.’’ by Sampson, Firth, and Towse
Marta O. Soares , Mark J. Sculpher, and Karl Claxton
We read with interest the commentary letter by Sampson
et al.1 on our article, ‘‘Health Opportunity Costs: Assessing
the Implications of Uncertainty Using Elicitation Methods
with Experts.’’2 Our article presents the design, implementa-
tion, and results of an elicitation exercise aiming to quanti-
tatively gather the (uncertain) beliefs of individuals on a set
of quantities. We use methods that our research team is
well versed in.3–7 The quantities elicited relate to a set of
key uncertainties identified in a previous piece of work—
Claxton et al.8—which evaluated the available evidence on
health opportunity costs (HOC) for the UK National
Health Service (NHS), a quantity that is important for sup-
porting policy decisions over investments using public
health system funds. Claxton et al.8 identified evidence on
the effects of changes in expenditure on the life year burden
of disease but no evidence on the likely effects of expendi-
ture on quality-adjusted life years (QALYs). Linking the
effects of expenditure on mortality burden of disease to
QALYs is hence the focus of our work.
The letter commends our study for its policy value
and for its methodological quality and rigor but, at the
same time, raises methodological concerns. The authors
provide no references to support their view that these
concerns minimize the policy relevance of our findings.
In this letter, we respond to these concerns.
The first methodological concern regards the expertise
of the individuals recruited, and we rebut this on 3
grounds. First, health care practitioners (the substantive
experts recruited into this study) directly observe the
health effects of the activities of the health system (linked
to expenditure), and hence we argue they are best placed
to evaluate the quantities of interest. Second, we followed
best practice9 in including, in our sample of experts, rep-
resentatives with specialism in all the different clinical
areas of interest (e.g., cardiologists, who have the rele-
vant experience in circulatory disease) and also individu-
als with expertise across clinical areas (e.g., general
practitioners, radiologists, anesthetists, and public health
specialists). The authors claim that those without a speci-
alism have no expertise, but this is incorrect as these indi-
viduals complement those with specialisms by providing
breadth across the different clinical areas, across the
types of technologies and services covered by NHS
expenditure, and across settings of care. Finally, the
authors claim the policy experts possess no substantive
expertise. This is true and has been made clear in our
study: policy experts were convened separately and asked
to elicit by reconciling the information elicited from clini-
cal experts with their own judgments. The fact that some
drew entirely on the judgments of substantive clinical
experts is a result in itself and was expected, indicating
that these individuals trust the judgments of individuals
with substantive expertise. This does not, in any way,
impair the validity of the elicitation exercise.
The second claim by the authors is that the elicited
quantities are not meaningful. It should be noted that
our article carefully lays out the definitions of the quanti-
ties elicited, and in supplementary material, we provide
the extensive materials used for training the experts and
the full questionnaire used in the elicitation. A number of
arguments were presented supporting the authors’ claim.
It is asserted that we have not used an existing frame-
work for elicitation, such as the Sheffield Elicitation
Framework (SHELF).10 A recent review identified that
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none of the existing frameworks for elicitation has been
developed specifically for health care.6 The protocol we
used for this exercise (which was defined a priori) was
developed in accordance with a number of these frame-
works, including the principles set out in SHELF.10 It
was developed for the health care context and tailored to
the specific needs of our exercise. The authors also claim
that the level of heterogeneity within disease areas com-
promises the definition of the quantity of interest. We
argue that heterogeneity is unavoidable, and clinicians
are used to integrating it into their judgments. Moreover,
many elicitations have been conducted over heteroge-
neous quantities, such as in attributing global foodborne
disease to specific foods11 or in defining the relationship
between future climate change and the increased risk of
armed conflict.12 This is not to say that eliciting under
heterogeneity is without its challenges, and we acknowl-
edge, in the discussion of our article, that this may have
resulted in the high level of observed within-expert uncer-
tainty (see third claim below).
The authors of the commentary also claim that the
assumption of conditional independence (used in defin-
ing the quantities for the elicitation) cannot be sustained
and justify this by the possibility of spillover effects. This
argument is, however, flawed. First, conditional indepen-
dence is well established in the elicitation literature as an
alternative to eliciting correlation.9 While the validity of
conditional independence may be difficult to demon-
strate, eliciting absolute quantities independently, as pro-
posed by the authors of the letter, is certainly not a valid
approach. Finally, in our study, spillover effects were
explicitly excluded by requesting individuals only to con-
sider expenditure and its health effects in the same dis-
ease area.
The third claim by the authors relates to the level of
uncertainty in responses. In the discussion to our article,
we acknowledge the challenges in eliciting policy-relevant
but broad-ranging quantities, which are by definition
uncertain. To support this claim, the authors question the
validity of some of the responses. At the end of every sec-
tion of the elicitation, participants were asked whether they
were confident the answers they had given reflected their
views and uncertainties. Response options were ‘‘yes,’’ ‘‘not
sure,’’ and ‘‘no.’’ We examined the qualitative feedback
from participants, and there was no suggestion that the
answers lacked face validity (see section ‘‘Face Validity and
Qualitative Feedback’’ of our article2 and supplemental
material). In addition, results were largely unchanged when
those who responded ‘‘no’’ or ‘‘not sure’’ were removed.
For these reasons, we dispute the substantive points
raised by Sampson et al.1 The authors conclude by
making the point that estimates are uncertain. There is
uncertainty surrounding both the causal effects of
changes in expenditure on mortality outcomes (which is
reported in a sequence of publications13–15) and how
these are likely to translate into QALY effects (reported
in this article2). The use of expert elicitation, which elicits
uncertainty as well as point estimates, is key to making
the judgments required to support policy explicit.16 This
allows for scrutiny, discussion, and accountability, which
promote the advancement of methods and applications
to inform policy choice and unavoidable decisions, such
as, how much can a health care system afford to pay for
the benefits offered by a new pharmaceutical? As with
estimates of any policy relevant parameter, the question
is, what does the balance of evidence suggests? We main-
tain our conclusion that the balance of evidence suggests
that the health effects of changes in expenditure are, if
anything, likely to be greater than suggested by the
mounting empirical estimates (evolving from Claxton
et al.8) of the effect of changes in health expenditure on
mortality outcomes.13–15
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